Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Sep 1;4(3):152-161.
doi: 10.1007/s13665-015-0119-3. Epub 2015 Jul 12.

The Challenge of Pulmonary Nontuberculous Mycobacterial Infection

Affiliations

The Challenge of Pulmonary Nontuberculous Mycobacterial Infection

Shannon Novosad et al. Curr Pulmonol Rep. .

Abstract

The incidence of nontuberculous mycobacterial (NTM) lung disease is increasing. Current treatment strategies are largely based on expert opinion. The lack of randomized clinical trials to inform treatment leave clinicians with many questions regarding the most effective and safe regimens. The risk-benefit ratio of therapy is often thought to favor observation given the chronic nature of the disease, multiple long-term antibiotics recommended for therapy, side effects associated with treatment, and perceived lack of efficacious therapies.

Keywords: MAC; Mycobacterium abscessus; antibiotic resistance; nontuberculous mycobacterial (NTM) pulmonary disease; surgical therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
NTM pulmonary disease amenable to surgical resection
Figure 1
Figure 1
NTM pulmonary disease amenable to surgical resection

References

    1. van der Werf MJ, Kodmon C, Katalinic-Jankovic V, Kummik T, Soini H, Richter E, et al. Inventory study of non-tuberculous mycobacteria in the European Union. BMC Infect Dis. 2014 Feb 6;14:62, 2334-14-62. - PMC - PubMed
    1. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367–416. - PubMed
    1. Marras TK, Prevots DR, Jamieson FB, Winthrop KL. Pulmonary MAC Outcomes Group. Opinions differ by expertise in Mycobacterium avium complex disease. Ann Am Thorac Soc. 2014 Jan;11(1):17–22. - PMC - PubMed
    1. Falkinham JO., 3rd. Surrounded by mycobacteria: nontuberculous mycobacteria in the human environment. J Appl Microbiol. 2009 Aug;107(2):356–67. - PubMed
    1. Adjemian J, Olivier KN, Prevots DR. Nontuberculous mycobacteria among patients with cystic fibrosis in the United States: screening practices and environmental risk. Am J Respir Crit Care Med. 2014 Sep 1;190(5):581–6. - PMC - PubMed